These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11859947)

  • 41. [Toxic dermatitis due to capecitabine: presentation of 2 cases and literature review].
    Gutiérrez-Pascual M; Sols-Candela M; Pinedo F; López-Estebaranz JL
    Actas Dermosifiliogr; 2009 May; 100(4):336-8. PubMed ID: 19463243
    [No Abstract]   [Full Text] [Related]  

  • 42. Noninflammatory bullae associated with epsilon-aminocaproic acid infusion.
    Brooke CP; Spiers EM; Omura EF
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 2):880-2. PubMed ID: 1469150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Acute respiratory failure due to Gemcitabine-induced pulmonary toxicity].
    Stern JB; Caliandro R; Lamer C; Lenoir S; Théodore C; Grunenwald D; Girard P
    Rev Mal Respir; 2002 Apr; 19(2 Pt1):253-6. PubMed ID: 12040327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Images in Medicine. A fortunate adverse drug reaction.
    Schattner A; Frumkin A
    Postgrad Med J; 1998 Jul; 74(873):422. PubMed ID: 9799918
    [No Abstract]   [Full Text] [Related]  

  • 45. Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine.
    Castellano D; Hitt R; Cortés-Funes H; Romero A; Rodriguez-Peralto JL
    J Clin Oncol; 2000 Feb; 18(3):695-6. PubMed ID: 10653886
    [No Abstract]   [Full Text] [Related]  

  • 46. Fluoxetine-induced hypersensitivity.
    Beer K; Albertini J; Medenica M; Busbey S
    Arch Dermatol; 1994 Jun; 130(6):803-4. PubMed ID: 8002659
    [No Abstract]   [Full Text] [Related]  

  • 47. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gemcitabine-induced pulmonary toxicity: case report and review of the literature.
    Gupta N; Ahmed I; Steinberg H; Patel D; Nissel-Horowitz S; Mehrotra B
    Am J Clin Oncol; 2002 Feb; 25(1):96-100. PubMed ID: 11823707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gemcitabine-related "pseudocellulitis": report of 2 cases and review of the literature.
    Tan DH; Bunce PE; Liles WC; Gold WL
    Clin Infect Dis; 2007 Sep; 45(5):e72-6. PubMed ID: 17682983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Warfarin-induced skin necrosis.
    Kozac N; Schattner A
    J Gen Intern Med; 2014 Jan; 29(1):248-9. PubMed ID: 23943419
    [No Abstract]   [Full Text] [Related]  

  • 51. BOOP as a rare complication of gemcitabine therapy.
    Kawsar HI; Spiro TP; Cocco A; Daw HA
    BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gemcitabine-Induced Subacute Cutaneous Lupus Erythematosus: A Case Report.
    Ben Zvi M; Vaknine H; Menczer J; Peled O; Ben Shem E; Schreiber L; Levy T
    Chemotherapy; 2016; 61(5):236-9. PubMed ID: 26928175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scleroderma-like cutaneous lesions induced by paclitaxel: a case study.
    Kupfer I; Balguerie X; Courville P; Chinet P; Joly P
    J Am Acad Dermatol; 2003 Feb; 48(2):279-81. PubMed ID: 12582404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatment.
    Badger J; Kang S; Uzieblo A; Srinivas S
    J Clin Oncol; 2005 Oct; 23(28):7224-5. PubMed ID: 16192608
    [No Abstract]   [Full Text] [Related]  

  • 55. Gemcitabine-induced pseudocellulitis.
    Caplan A; Chu DH; Rosenbach M; Svoboda J
    Cutis; 2018 Nov; 102(5):E20-E23. PubMed ID: 30566560
    [No Abstract]   [Full Text] [Related]  

  • 56. Abundance of plasma cells in a case of lipodermatosclerosis.
    Fernandez-Flores A; Manjón JA
    Acta Dermatovenerol Croat; 2010; 18(1):27-31. PubMed ID: 20361885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Interstitial lung disease in a patient given gemcitabine].
    Hammerer V; Schmitz N; Pauli G; Quoix E
    Rev Pneumol Clin; 2002 Feb; 58(1):23-6. PubMed ID: 11981501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Phalanges necrosis--a rare manifestation of "hand-foot" syndrome induced by gemcitabine used in the second--line therapy for progressive ovarian cancer. A case report].
    Gołka KA; Kobierski J; Milczek T; Emerich J
    Ginekol Pol; 2009 Apr; 80(4):295-8. PubMed ID: 19507565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gemcitabine-induced pseudocellulitis: a case report and review of the literature.
    Bami H; Goodman C; Boldt G; Vincent M
    Curr Oncol; 2019 Oct; 26(5):e703-e706. PubMed ID: 31708665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An autopsy case of acute pulmonary toxicity associated with gemcitabine.
    Maniwa K; Tanaka E; Inoue T; Kato T; Sakuramoto M; Minakuchi M; Maeda Y; Noma S; Kobashi Y; Taguchi Y
    Intern Med; 2003 Oct; 42(10):1022-5. PubMed ID: 14606719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.